Senti Biosciences (SNTI) Financials: Revenue & Earnings

SNTI price $0.21 +0.02 +10.87%

Ticker
SNTI
Price
$0.21
Change
+0.02 +10.87%
Market cap ?
$6.45M
Beta ?
2.22
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
60
Value
59
Quality
22
Growth
100

Stocklytics score rationale: value 59, quality 22, growth 100.

Fair value

SNTI fair value $21.67. Price $0.21. Price is 99% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare SNTI

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.21—15.87K
2026-08-14-0.41-0.2717.00K17.00K
2026-05-14-0.14-0.278.00K16.00K
2026-03-27-0.53-0.4322.00K1.00M
2025-11-13-0.69-0.59—250.00K
2025-08-07-0.56-0.90—500.00K
2025-05-06-1.41-0.58—1.30M
2025-03-20-0.67-3.135.86M2.80M
2024-11-14-6.31———
2024-08-13-2.45———
2024-05-09-2.60———
2024-03-21-4.20-0.23333.00K300.00K
2023-11-13-2.50-0.48338.00K668.50K
2023-08-11-4.20-4.80937.00K500.00K
2023-05-09-4.20-4.801.04M500.00K
2023-03-22-4.20-4.7059.00K470.00K
2022-11-10-3.80-5.201.77M1.54M
2022-08-15-5.65—1.40M—
2022-08-09-2.70—854.00K—
2022-03-07-2.50—543.00K—
2021-11-10-2.61—926.00K—
2021-08-06-2.75—778.00K—
2021-07-02-0.00—72.00K—
2020-12-31-0.75—2.00K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-21Rajangam KanyaSell19.95K——
2026-10-21Lu Timothy KSell157.31K——
2026-03-09Rajangam KanyaSell10.76K——
2026-03-09Lu Timothy KSell80.67K——
2026-02-02Rajangam KanyaSell1.38K——
2026-02-02Lu Timothy KSell4.19K——
2025-07-18Baum Bryan DanielBuy43.90K$1.9585.61K
2025-07-18Baum Bryan DanielOther0——
2025-06-25Collins James J.Buy21.95K$2.0545.00K
2025-06-25Hsiung FengBuy21.95K$2.0545.00K
2025-06-25Schulz FranBuy21.95K$2.0545.00K
2025-06-25COOPERSTONE BRENDABuy21.95K$2.0545.00K
2025-06-25Tang Donald FBuy21.95K$2.0545.00K
2025-06-25Mathers Edward TBuy21.95K$2.0545.00K
2025-03-10Celadon Partners SPV 24Buy9.78M——
2025-03-10Celadon Partners SPV 24Sell9.78K——
2025-03-10New Enterprise Associates 15, L.P.Buy3.33M——
2025-03-10New Enterprise Associates 15, L.P.Sell3.33K——
2025-03-10BAYER HEALTHCARE LLCBuy2.22M——
2025-03-10BAYER HEALTHCARE LLCSell2.22K——
2025-03-10Rajangam KanyaBuy33.00K$2.2574.25K
2025-03-10Rajangam KanyaSell33$2.2574
2025-03-07Mathers Edward TBuy43.90K$3.52154.53K
2025-03-07Schulz FranBuy43.90K$3.52154.53K
2025-03-07Collins James J.Buy43.90K$3.52154.53K
2025-03-07Tang Donald FBuy43.90K$3.52154.53K
2025-03-07COOPERSTONE BRENDABuy43.90K$3.52154.53K
2025-03-07Hsiung FengBuy43.90K$3.52154.53K
2025-03-07Hsiung FengOther0——
2025-03-07Cross John Harry IIIBuy174.20K$3.52613.18K
2025-03-07Rajangam KanyaBuy78.36K——
2025-03-07Lu Timothy KBuy642.36K——
2025-03-06Celadon Partners SPV 24Other6.67M$2.3015.33M
2025-03-06Celadon Partners SPV 24Other9.78M$2.2522.00M
2025-03-06New Enterprise Associates 15, L.P.Other0——
2025-03-06New Enterprise Associates 15, L.P.Other3.33M——
2025-03-06New Enterprise Associates 15, L.P.Other13.71K——
2025-03-06Rajangam KanyaBuy235.09K$3.97933.30K
2025-03-06Lu Timothy KBuy1.93M$3.977.65M
2025-03-03Cross John Harry IIIOther0——
2025-02-06Lu Timothy KSell545$4.362.38K
2025-02-06Rajangam KanyaSell182$4.37795
2025-02-04Lu Timothy KSell3.92K$4.0715.96K
2025-02-04Rajangam KanyaSell1.30K$4.075.28K
2024-12-09BAYER HEALTHCARE LLCBuy3.33M$2.307.67M
2024-12-09BAYER HEALTHCARE LLCBuy2.22K——
2024-12-09Tang Donald FBuy12.50K$6.5281.50K
2024-12-09Tang Donald FOther0——
2024-12-09Schulz FranBuy12.50K$6.5281.50K
2024-12-09Schulz FranOther0——
2024-12-09Rajangam KanyaBuy49.50K$2.30113.85K
2024-12-09Rajangam KanyaBuy33$2.2574
2024-07-10Mathers Edward TBuy62.50K$0.3119.38K
2024-07-10Farokhzad OmidBuy62.50K$0.3119.38K
2024-07-10Collins James J.Buy62.50K$0.3119.38K
2024-07-10COOPERSTONE BRENDABuy62.50K$0.3119.38K
2024-05-04Li YvonneOther0——
2024-02-01Rajangam KanyaBuy152.00K$0.4669.92K
2024-02-01Rajangam KanyaBuy101.00K——
2024-02-01Lu Timothy KBuy306.00K——
2024-02-01Lu Timothy KBuy459.00K$0.46211.14K
2024-02-01KNOBELMAN DEBORAHBuy152.00K$0.4669.92K
2024-02-01KNOBELMAN DEBORAHBuy101.00K——
2023-06-16Mathers Edward TBuy62.50K$0.9961.88K
2023-06-16Berland Susan DBuy62.50K$0.9961.88K
2023-06-16Collins James J.Buy62.50K$0.9961.88K
2023-06-16COOPERSTONE BRENDABuy62.50K$0.9961.88K
2023-06-16Farokhzad OmidBuy62.50K$0.9961.88K
2023-02-01Lee Philip JBuy195.00K$1.81352.95K
2023-02-01KNOBELMAN DEBORAHBuy130.00K$1.81235.30K
2023-02-01Rajangam KanyaBuy130.00K$1.81235.30K
2023-02-01Lu Timothy KBuy630.00K$1.811.14M
2022-10-03KNOBELMAN DEBORAHBuy240.00K——
2022-10-03KNOBELMAN DEBORAHBuy30.00K——
2022-07-18Rajangam KanyaBuy327.75K$1.80589.95K
2022-07-18Rajangam KanyaBuy327.75K——
2022-07-13Mathers Edward TBuy125.00K$1.75218.75K
2022-07-13Collins James J.Buy125.00K$1.75218.75K
2022-07-13Mathers Edward TBuy125.00K——
2022-07-13Farokhzad OmidBuy125.00K——
2022-07-13Berland Susan DBuy125.00K——
2022-07-13Collins James J.Buy125.00K——
2022-07-13Epstein David RBuy125.00K——
2022-07-13COOPERSTONE BRENDABuy125.00K——
2022-07-05Rajangam KanyaOther0——
2022-06-08BAYER HEALTHCARE LLCOther0——
2022-06-08BAYER HEALTHCARE LLCSell0——
2022-06-08Mathers Edward TOther0——
2022-06-08New Enterprise Associates 15, L.P.Sell0——
2022-06-08New Enterprise Associates 15, L.P.Sell137.12K——
2022-06-08Lee Philip JSell0——
2022-06-08Lee Philip JSell40.42K——
2022-06-08Lee Philip JSell1.15M$9.9211.42M
2022-06-08Berland Susan DSell17.61K$7.87138.61K
2022-06-08Collins James J.Sell0——
2022-06-08Collins James J.Sell7.60K——
2022-06-08Collins James J.Sell3.52K$7.4726.31K
2022-06-08COOPERSTONE BRENDASell31.44K$3.1298.09K
2022-06-08KNOBELMAN DEBORAHSell146.78K$7.871.16M
2022-06-08KNOBELMAN DEBORAHSell947.71K$9.929.40M

Institutional holders

Latest filed quarter: Q4 2025.

HolderSharesChangeChange %Value
8VC GP I, LLC0-253.75K-100.00%0

Earnings and financials

Senti Biosciences, Inc. (SNTI) trades at $0.21, with a market cap of $6.45M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Senti Biosciences (SNTI) Financials: Revenue & Earnings

SNTI$0.21+0.02 +10.87%

$6.45M

Market Cap

—

P/E

—

Forward P/E

60

Score

Price History